Theravance Biopharma
TBPH
#6855
Rank
A$0.66 B
Marketcap
Country
$13.58
Share price
2.17%
Change (1 day)
-14.23%
Change (1 year)

Earnings for Theravance Biopharma (TBPH)

Earnings in 2024 (TTM): -A$57.87 Million

According to Theravance Biopharma 's latest financial reports the company's current earnings are A$62.01 Million. In 2023 the company made an earning of -A$74.82 Million, an increase over its 2022 earnings that were of -A$0.15 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Theravance Biopharma from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$57.87 Million-22.66%
2023 -A$74.82 Million-46.92%
2022 -A$0.15 Billion-57.85%
2021 -A$0.34 Billion-23.16%
2020 -A$0.44 Billion18.56%
2019 -A$0.37 Billion6.9%
2018 -A$0.35 Billion-16.79%
2017 -A$0.42 Billion50.48%
2016 -A$0.28 Billion-0.39%
2015 -A$0.28 Billion-21.42%
2014 -A$0.36 Billion47.6%
2013 -A$0.24 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.32 B-660.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.21 B-475.07%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B-344.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.18 Billion 1,922.40%๐Ÿ‡บ๐Ÿ‡ธ USA